TPH1 and systemic lupus erythematosus: Although the Tph frequency among SLE patients follows a bimodal distribution, with a small subgroup of patients displaying higher levels of circulating Tph cells, we did not find an association with clinical parameters, such as disease duration, disease activity, autoantibody status, or treatment (Supplementary Fig. S6).